Cybin (HELP) Other Non Operating Income (2020 - 2025)
Cybin (HELP) reported Other Non Operating Income of $1403.0 for Q2 2025, down 21.68% on a YoY basis from $1791.3 in Q2 2024, and down 89.77% quarter-over-quarter from $13716.4 in Q4 2024.
Cybin (HELP) Other Non Operating Income (2020 - 2025) Analysis & Trends
Cybin has reported Other Non Operating Income for 6 years, with the latest figure at $1403.0 in Q2 2025.
- For the quarter ending Q2 2025, Other Non Operating Income fell 21.68% year-over-year to $1403.0; the trailing twelve-month figure through Jun 2025 stood at -$1.5 million (down 150.92% YoY), and the FY2023 full-year result was $31504.4, down 78.63% from the prior year.
- Other Non Operating Income for Q2 2025 stood at $1403.0, down from $13716.4 in the prior quarter.
- The five-year high for Other Non Operating Income was $1.7 million in Q3 2022, with the low at -$1.5 million in Q3 2024.
- Historically, Other Non Operating Income has averaged $311502.0 across 5 years, with a median of $19467.9 in 2021.
- Annual changes were most pronounced in 2021 — Other Non Operating Income soared 8104.26% — and 2024, when it tumbled 200.67%.
- Cybin's Other Non Operating Income stood at $12693.4 in 2021, then jumped by 7752.59% to $996759.1 in 2022, then plunged by 100.25% to -$2531.9 in 2023, then jumped by 641.73% to $13716.4 in 2024, then slumped by 89.77% to $1403.0 in 2025.
- The last three Other Non Operating Income figures came in at $1403.0 (Q2 2025), $13716.4 (Q4 2024), and -$1.5 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1,403.01 |
| Dec 31, 2024 | 13,716.39 |
| Sep 30, 2024 | -1.48 Mn |
| Jun 30, 2024 | 1,791.29 |
| Dec 31, 2023 | -2,531.94 |
| Sep 30, 2023 | 1.47 Mn |
| Jun 30, 2023 | 1.40 Mn |
| Dec 31, 2022 | 996,759.08 |
| Sep 30, 2022 | 1.68 Mn |
| May 31, 2022 | 6,247.57 |
| Feb 28, 2022 | 112,229.41 |
| Dec 31, 2021 | 12,693.38 |
| Sep 30, 2021 | 123,133.44 |
| Jun 30, 2021 | 25,219.34 |
| Dec 31, 2020 | -41,420.95 |
| Sep 30, 2020 | 1,500.85 |
| Jun 30, 2020 | -95,920.13 |